Line 5: |
Line 5: |
| !Author Content (Pending or Complete) | | !Author Content (Pending or Complete) |
| !Editor Reviewed (Date) | | !Editor Reviewed (Date) |
| + | !Notes |
| |- | | |- |
| |'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR) | | |'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR) |
| + | | |
| | | | | |
| | | | | |
Line 12: |
Line 14: |
| | Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease | | | Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
Line 17: |
Line 20: |
| | Chronic Neutrophilic Leukemia (CNL)||Disease | | | Chronic Neutrophilic Leukemia (CNL)||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
Line 22: |
Line 26: |
| | Polycythaemia Vera (PV)||Disease | | | Polycythaemia Vera (PV)||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
Line 27: |
Line 32: |
| | Primary Myelofibrosis (PMF)||Disease | | | Primary Myelofibrosis (PMF)||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
Line 32: |
Line 38: |
| | Essential Thrombocythaemia (ET)||Disease | | | Essential Thrombocythaemia (ET)||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
Line 37: |
Line 44: |
| | Chronic Eosinophilic Leukemia, Not Otherwise Specified||Disease | | | Chronic Eosinophilic Leukemia, Not Otherwise Specified||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
Line 42: |
Line 50: |
| | Myeloproliferative Neoplasm (MPN), Unclassifiable||Disease | | | Myeloproliferative Neoplasm (MPN), Unclassifiable||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR | | |'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR |
| + | | |
| | | | | |
| | | | | |
Line 51: |
Line 61: |
| | Cutaneous Mastocytosis||Disease | | | Cutaneous Mastocytosis||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
Line 56: |
Line 67: |
| | Systemic Mastocytosis||Disease | | | Systemic Mastocytosis||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
Line 61: |
Line 73: |
| | Mast Cell Sarcoma||Disease | | | Mast Cell Sarcoma||Disease |
| | ||FQR | | | ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR | | |'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR | | | Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR | | | Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR | | | Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease|| ||FQR | | | Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''|| ||FQR | | |'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Chronic Myelomonocytic Leukemia (CMML)||Disease|| ||FQR | | | Chronic Myelomonocytic Leukemia (CMML)||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR | | | Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Juvenile Myelomonocytic Leukemia (JMML)||Disease|| ||FQR | | | Juvenile Myelomonocytic Leukemia (JMML)||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR | | | Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR | | | Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR | | |'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR | | | Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR | | | Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR | | | Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease|| ||FQR | | | Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease|| ||FQR | | | Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myelodysplastic Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR | | | Myelodysplastic Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myelodysplastic Syndrome (MDS), Unclassifiable||Disease|| ||FQR | | | Myelodysplastic Syndrome (MDS), Unclassifiable||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Refractory Cytopenia of Childhood||Disease|| ||FQR | | | Refractory Cytopenia of Childhood||Disease|| ||FQR |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
Line 151: |
Line 185: |
| |Jennelle Hodge (JH) | | |Jennelle Hodge (JH) |
| |Complete | | |Complete |
| + | | |
| | | | | |
| |- | | |- |
− | |'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying Zou ||JH | + | |'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying Zou||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH | | | Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang||JH | | | Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori||JH | | | Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang||JH | | | Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
− | | Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou ||JH | + | | Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+Path Resident||JH | | | Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+Path Resident||JH |
| + | | |
| | | | | |
| | | | | |
Line 184: |
Line 226: |
| |JH | | |JH |
| |Complete | | |Complete |
| + | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH | | | Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH | | | Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty||JH | | | Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH | | | Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH | | | Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH | | | Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH | | | Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy via Greg Conboy (Monash Health)||JH | | | Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy via Greg Conboy (Monash Health)||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH | | | Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg Conboy (Monash Health)||JH | | | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg Conboy (Monash Health)||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Path Resident (Iris Martin)||JH | | | Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Path Resident (Iris Martin)||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH | | |Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH | | |Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH | | |''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH | | | Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge||JH | | | Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge||JH | | | Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH | | | Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH | | | Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Pure Erythroid Leukemia||Disease||Ash Yenamandra||JH | | | Pure Erythroid Leukemia||Disease||Ash Yenamandra||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH | | | Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH | | | Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang||JH | | | Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH | | |Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty Greipp||JH | | |'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty Greipp||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley||JH | | | Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley||JH | | | Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH | | |Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH | | |'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Acute Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH | | | Acute Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH | | | Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH | | | Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH | | | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH | | | Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH | | | ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH | | | ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA) | | |'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA) |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''|| ||YA | | |'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| ||YA | | | B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA | | |'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA | | |Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA | | |NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP) | | |'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP) |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP | | |Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Monoclonal B-cell Lymphocytosis||Disease|| ||SP | | | Monoclonal B-cell Lymphocytosis||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |B-cell Prolymphocytic Leukemia||Disease|| ||SP | | |B-cell Prolymphocytic Leukemia||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Splenic Marginal Zone Lymphoma||Disease|| ||SP | | |Splenic Marginal Zone Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Hairy Cell Leukemia||Disease|| ||SP | | |Hairy Cell Leukemia||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''|| ||SP | | |'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease|| ||SP | | | Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Hairy Cell Leukemia Variant||Disease|| ||SP | | | Hairy Cell Leukemia Variant||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Lymphoplasmacytic Lymphoma||Disease|| ||SP | | |Lymphoplasmacytic Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Waldenstrom Macroglobulinemia||Disease|| ||SP | | | Waldenstrom Macroglobulinemia||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP | | |IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP | | |'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Mu Heavy Chain Disease||Disease|| ||SP | | | Mu Heavy Chain Disease||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Gamma Heavy Chain Disease||Disease|| ||SP | | | Gamma Heavy Chain Disease||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Alpha Heavy Chain Disease||Disease|| ||SP | | | Alpha Heavy Chain Disease||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Plasma Cell Neoplasms||'''''Overview'''''|| ||SP | | |Plasma Cell Neoplasms||'''''Overview'''''|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP | | | Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Plasma Cell Myeloma||Disease|| ||SP | | | Plasma Cell Myeloma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Plasma Cell Myeloma Variants||Disease|| ||SP | | | Plasma Cell Myeloma Variants||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Plasmacytoma||Disease|| ||SP | | | Plasmacytoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |''''' Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP | | |''''' Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Primary Amyloidosis||Disease|| ||SP | | | Primary Amyloidosis||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Light Chain and Heavy Chain Deposition Disease||Disease|| ||SP | | | Light Chain and Heavy Chain Deposition Disease||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP | | |'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | POEMS Syndrome||Disease|| ||SP | | | POEMS Syndrome||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | TEMPI Syndrome||Disease|| ||SP | | | TEMPI Syndrome||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease|| ||SP | | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Nodal Marginal Zone Lymphoma||Disease|| ||SP | | |Nodal Marginal Zone Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Paediatric Nodal Marginal Zone Lymphoma||Disease|| ||SP | | | Paediatric Nodal Marginal Zone Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Follicular Lymphoma||Disease|| ||SP | | |Follicular Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Testicular Follicular Lymphoma||Disease|| ||SP | | | Testicular Follicular Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | In Situ Follicular Neoplasia||Disease|| ||SP | | | In Situ Follicular Neoplasia||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Duodenal-Type Follicular Lymphoma||Disease|| ||SP | | | Duodenal-Type Follicular Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Paediatric-Type Follicular Lymphoma||Disease|| ||SP | | |Paediatric-Type Follicular Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP | | |Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP | | |Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Mantle Cell Lymphoma||Disease|| ||SP | | |Mantle Cell Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Leukemic Non-Nodal Mantle Cell Lymphoma||Disease|| ||SP | | | Leukemic Non-Nodal Mantle Cell Lymphoma||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | In Situ Mantle Cell Neoplasia||Disease|| ||SP | | | In Situ Mantle Cell Neoplasia||Disease|| ||SP |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC) | | |Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC) |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC | | |T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC | | |Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC | | |Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC | | |EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC | | |EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation||Disease|| ||GC | | |Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Fibrin-Associated Diffuse Large B-cell Lymphoma||Disease|| ||GC | | | Fibrin-Associated Diffuse Large B-cell Lymphoma||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Lymphomatoid Granulomatosis||Disease|| ||GC | | |Lymphomatoid Granulomatosis||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC | | |Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Intravascular Large B-cell Lymphoma||Disease|| ||GC | | |Intravascular Large B-cell Lymphoma||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |ALK-Positive Large B-cell Lymphoma||Disease|| ||GC | | |ALK-Positive Large B-cell Lymphoma||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Plasmablastic Lymphoma||Disease|| ||GC | | |Plasmablastic Lymphoma||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Primary Effusion Lymphoma||Disease|| ||GC | | |Primary Effusion Lymphoma||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC | | |'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Multicentric Castleman Disease||Disease|| ||GC | | | Multicentric Castleman Disease||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC | | | HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease|| ||GC | | | HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Burkitt Lymphoma||Disease|| ||GC | | |Burkitt Lymphoma||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC | | |Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC | | |'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC | | | High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC | | | High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC | | |B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Associate Editor?? | | |'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Associate Editor?? |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |T-cell Prolymphocytic Leukemia||Disease|| || | | |T-cell Prolymphocytic Leukemia||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |T-cell Large Granular Lymphocytic Leukemia||Disease|| || | | |T-cell Large Granular Lymphocytic Leukemia||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Chronic Lymphoproliferative Disorder of NK Cells||Disease|| || | | |Chronic Lymphoproliferative Disorder of NK Cells||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Aggressive NK-cell Leukemia||Disease|| || | | |Aggressive NK-cell Leukemia||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''|| || | | |'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease|| || | | | Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form||Disease|| || | | | Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease|| || | | | Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Severe Mosquito Bite Allergy||Disease|| || | | | Severe Mosquito Bite Allergy||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Adult T-cell Leukemia/Lymphoma||Disease|| || | | |Adult T-cell Leukemia/Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| || | | |Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| || | | |'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Enteropathy-Associated T-cell Lymphoma||Disease|| || | | | Enteropathy-Associated T-cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease|| || | | | Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| || | | | Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| || | | | Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Hepatosplenic T-cell Lymphoma||Disease|| || | | |Hepatosplenic T-cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| || | | |Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Mycosis Fungoides||Disease|| || | | |Mycosis Fungoides||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Sézary Syndrome||Disease|| || | | |Sézary Syndrome||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''|| || | | |'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Lymphomatoid Papulosis||Disease|| || | | | Lymphomatoid Papulosis||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease|| || | | | Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| || | | |'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease|| || | | | Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| || | | | Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease|| || | | | Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| || | | | Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| || | | |Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''|| || | | |'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Angioimmunoblastic T-cell Lymphoma||Disease|| || | | | Angioimmunoblastic T-cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Follicular T-cell Lymphoma||Disease|| || | | | Follicular T-cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| || | | | Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Anaplastic Large Cell Lymphoma, ALK-Positive||Disease|| || | | |Anaplastic Large Cell Lymphoma, ALK-Positive||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Anaplastic Large Cell Lymphoma, ALK-Negative||Disease|| || | | |Anaplastic Large Cell Lymphoma, ALK-Negative||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| || | | |Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor?? | | |'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor?? |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| || | | |Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| || | | |'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Nodular Sclerosis Classic Hodgkin Lymphoma||Disease|| || | | | Nodular Sclerosis Classic Hodgkin Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease|| || | | | Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Mixed Cellularity Classic Hodgkin Lymphoma||Disease|| || | | | Mixed Cellularity Classic Hodgkin Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease|| || | | | Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| || | | |'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Lymphomas Associated with HIV Infection||Disease|| || | | |Lymphomas Associated with HIV Infection||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| || | | |'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease|| || | | | Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease|| || | | | Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |''''' Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| || | | |''''' Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Monomorphic B-cell PTLD||Disease|| || | | | Monomorphic B-cell PTLD||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Monomorphic T/NK-cell PTLD||Disease|| || | | | Monomorphic T/NK-cell PTLD||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| || | | | Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease|| || | | |Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| || | | |'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Histiocytic Sarcoma||Disease|| || | | |Histiocytic Sarcoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| || | | |'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Langerhans Cell Histiocytosis||Disease|| || | | | Langerhans Cell Histiocytosis||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Langerhans Cell Sarcoma||Disease|| || | | | Langerhans Cell Sarcoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Indeterminate Dendritic Cell Tumour||Disease|| || | | |Indeterminate Dendritic Cell Tumour||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Interdigitating Dendritic Cell Sarcoma||Disease|| || | | |Interdigitating Dendritic Cell Sarcoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Follicular Dendritic Cell Sarcoma||Disease|| || | | |Follicular Dendritic Cell Sarcoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| || | | | Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Fibroblastic Reticular Cell Tumor||Disease|| || | | |Fibroblastic Reticular Cell Tumor||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Disseminated Juvenile Xanthogranuloma||Disease|| || | | |Disseminated Juvenile Xanthogranuloma||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| |Erdheim-Chester Disease||Disease|| || | | |Erdheim-Chester Disease||Disease|| || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |- | | |- |
| | || || || | | | || || || |
| + | | |
| | | | | |
| | | | | |
| |} | | |} |